Diarrhea Labs and Next Steps: A Clinical Guide to Diagnosis and Treatment

Start With Severity, Not a Shopping List of Labs

Diarrhea is a symptom, not one disease. A viral illness that started yesterday, diarrhea after antibiotics, six weeks of painless watery stools, and bloody diarrhea after undercooked food require different decisions.

The Infectious Diseases Society of America guideline recommends evaluating people with fever or bloody diarrhea for pathogens in which antimicrobial treatment may help, while also recognizing that most acute watery diarrhea is self-limited. It emphasizes exposure history and targeted testing rather than ordering every available stool test. 1

Three questions determine the next step

1. Could dehydration or another complication be developing? Look at fluid intake, vomiting, urine output, dizziness, mental status, heart rate, and vulnerability due to age or illness.
2. Is this likely inflammatory or invasive? Blood, substantial fever, severe focal pain, or sepsis features raise concern.
3. Is the duration or exposure pattern changing the differential? Recent antibiotics, healthcare exposure, international travel, untreated water, immunosuppression, a sick contact cluster, or symptoms beyond two to four weeks each shift the workup.

When Diarrhea Needs Urgent Evaluation

Urgency cannot be reduced to one stool count or one temperature. Prompt in-person evaluation is appropriate when any of these are present:

• inability to keep fluids down
• very low urine output, fainting, confusion, marked weakness, or other signs of significant dehydration
• blood in the stool, maroon stool, or black tarry stool
• severe or worsening abdominal pain, abdominal rigidity, or marked distention
• high fever with systemic illness
• signs of shock or sepsis
• new diarrhea in a person who is substantially immunocompromised
• diarrhea with serious pregnancy, infant, frailty, or older-adult concerns
• recent antibiotics or hospitalization plus frequent unexplained watery stool and systemic illness

Black stool can also occur after bismuth or iron, but that history should not be used to dismiss possible gastrointestinal bleeding when the appearance or symptoms are concerning.

Children and older adults can dehydrate faster, and pediatric assessment uses age-specific signs and fluid plans. A fixed rule such as "all diarrhea after 48 hours requires telehealth" is too broad; severity and trajectory matter more.

What Causes Diarrhea?

Acute infectious diarrhea

Viruses such as norovirus commonly cause abrupt vomiting and watery, nonbloody diarrhea. Bacteria include Campylobacter, Salmonella, Shigella, diarrheagenic Escherichia coli, and others. Giardia, Cryptosporidium, Cyclospora, and Entamoeba histolytica become more relevant with particular travel, water, immune, or duration patterns.

Exposure clues include restaurant or household clusters, daycare, animal contact, raw shellfish, undercooked meat, unpasteurized products, recreational water, well water, and recent international travel. No exposure detail identifies an organism with certainty, but it helps select the right test.

Antibiotic-associated diarrhea and C. difficile

Antibiotics can cause mild diarrhea without Clostridioides difficile, but they also increase CDI risk. Healthcare exposure, older age, prior CDI, immunosuppression, and certain antibiotics add risk. CDI is a clinical diagnosis supported by stool testing, not a laboratory result in isolation.

The 2021 American College of Gastroenterology guideline describes CDI as toxin-producing C. difficile causing diarrhea and colonic inflammation. Testing should focus on people with compatible symptoms rather than formed stool or routine "tests of cure." 2

Medication and supplement effects

Common contributors include metformin, magnesium-containing products, colchicine, antibiotics, some acid-suppressing drugs, laxatives, sugar alcohols, and several cancer or immune therapies. GLP-1 receptor agonists and dual GIP/GLP-1 medicines can cause diarrhea as well as nausea, vomiting, or constipation, particularly during dose escalation. A 2025 systematic review found gastrointestinal adverse events were common across GLP-1-based anti-obesity trials, with patterns varying by agent. 3

Do not automatically stop a necessary prescription for two to four weeks. The better step is to compare symptom timing with initiation or dose changes, assess severity, and make a medication-specific plan.

Chronic noninfectious diarrhea

Important possibilities include:

• irritable bowel syndrome with diarrhea, usually with recurrent abdominal pain related to bowel movements
• functional diarrhea, usually without predominant pain
• celiac disease
• inflammatory bowel disease
• microscopic colitis
• bile acid diarrhea
• medication or supplement effects
• pancreatic insufficiency or other malabsorption
• lactose or other carbohydrate intolerance
• hyperthyroidism
• postsurgical changes
• colorectal neoplasia or another structural disorder

Rare hormone-secreting tumors exist, but broad chromogranin A or 5-HIAA testing is not a routine first step for ordinary chronic diarrhea. Those tests belong to a compatible, specific clinical picture.

The History That Changes Testing

Before choosing labs, document:

• exact start date and daily stool frequency
• watery, greasy, bloody, black, pale, or mucus-containing appearance
• vomiting, fever, pain location, bloating, urgency, or incontinence
• nighttime symptoms or symptoms despite fasting
• weight change
• fluid intake and urine output
• foods, water, travel, animals, sick contacts, and outbreaks
• all prescriptions, over-the-counter medicines, supplements, and recent dose changes
• antibiotics and healthcare exposure over the preceding months
• prior bowel surgery, gallbladder removal, radiation, or pancreatic disease
• immune status and relevant family history

The National Institute of Diabetes and Digestive and Kidney Diseases describes this history, examination, and targeted stool, blood, breath, or endoscopic testing as the core diagnostic pathway. 4

Which Stool Tests Are Used for Acute Diarrhea?

Stool culture or multiplex molecular panel

Testing is most useful when the result could alter treatment, infection control, or public-health action. Typical reasons include bloody stool, substantial fever, severe abdominal pain, sepsis signs, persistent symptoms, immunocompromise, hospitalization, or a suspected outbreak.

Multiplex PCR panels detect multiple organisms quickly, but they can detect more than one target and may identify nucleic acid that does not fully explain the illness. Interpretation still requires the clinical picture. Traditional culture remains important in selected cases for susceptibility testing and public-health characterization.

When Shiga toxin-producing E. coli is possible, the test strategy should detect Shiga toxin or its genes and distinguish relevant strains. Antibiotics and antimotility medicines can be harmful in some STEC infections because of concern for hemolytic uremic syndrome; management should not be improvised from a generic antibiotic list. 1

C. difficile testing

Test patients with unexplained new diarrhea when CDI is clinically plausible. Laboratories may use toxin assays, glutamate dehydrogenase, nucleic acid amplification, or multistep algorithms. Molecular tests are sensitive but can be positive in colonized people, so testing formed stool or asymptomatic patients creates misleading results.

Repeat testing to prove cure is not recommended because tests can remain positive after symptoms resolve. The 2026 AGA update likewise frames CDI as compatible symptoms plus supportive testing and favors multistep testing for diagnostic accuracy. 5

Parasite testing

Targeted Giardia testing is useful with persistent watery diarrhea, compatible travel, untreated water exposure, daycare exposure, or other risk. Broader ova-and-parasite or molecular testing depends on geography, immune status, duration, and exposure. The old rule that every evaluation requires three O&P samples is not a universal modern standard.

Blood Tests: When They Add Value

Blood tests are often unnecessary for a healthy adult with a brief, improving watery illness. They become useful when assessing dehydration, systemic illness, anemia, inflammation, malabsorption, or a chronic cause.

Depending on the presentation, useful tests can include:

• complete blood count
• electrolytes, kidney function, and bicarbonate
• liver tests when the history suggests hepatobiliary disease or systemic illness
• C-reactive protein in selected inflammatory presentations
• celiac serology
• thyroid-stimulating hormone when hyperthyroidism is plausible
• HIV testing or immune evaluation when clinically indicated

There is no universal "diarrhea blood panel." A test is valuable when its result changes the diagnostic branch.

Chronic Watery Diarrhea: A Different Workup

Once symptoms persist beyond about four weeks, repeatedly treating the problem as an infection misses common diagnoses. The British Society of Gastroenterology guideline recommends an organized assessment for malabsorption, inflammation, bile acid diarrhea, microscopic colitis, and structural disease based on age and presentation. 6

Celiac disease testing

Testing usually begins with tissue transglutaminase IgA plus a total IgA level while the patient is still eating gluten. IgG-based testing may be needed in IgA deficiency. Starting a gluten-free diet before testing can reduce diagnostic accuracy.

The 2023 ACG guideline explains that serology is useful for initial screening and that intestinal biopsy is required to confirm diagnosis in most adults. A gluten-free diet is treatment for confirmed celiac disease, not a neutral diagnostic trial before evaluation. 7

Fecal calprotectin or lactoferrin

These stool markers help identify intestinal inflammation and can help distinguish inflammatory bowel disease from functional disorders in an appropriate setting. They are not cancer tests and are not perfectly specific: infection, NSAID use, and other inflammation can raise results.

The ACG IBS guideline suggests fecal calprotectin in patients with suspected IBS and diarrhea symptoms to help rule out IBD, along with celiac serology. It supports a positive diagnostic strategy for IBS rather than an endless exclusion workup when alarm features are absent. 8

Giardia and bile acid diarrhea

The AGA guideline for chronic watery diarrhea recommends Giardia testing and suggests evaluation for bile acid diarrhea. It recommends against routine broad ova-and-parasite testing in people without relevant travel or immigration exposure. 9

Bile acid diarrhea can occur without obvious surgery and may be mistaken for IBS-D. Testing availability varies by country, so the diagnostic approach may include specialized tests or a carefully monitored therapeutic trial.

Microscopic colitis

Microscopic colitis often causes chronic watery, nonbloody diarrhea. The colon may look normal during colonoscopy, so biopsies from appropriate colonic segments are essential. European guidance defines the condition by its clinical pattern and characteristic histology, not by a visible ulcer or mass. 10

When colonoscopy or imaging is considered

Colonoscopy may be appropriate for bleeding, iron-deficiency anemia, unexplained weight loss, age-appropriate colorectal evaluation, suspected IBD, persistent unexplained diarrhea, or suspected microscopic colitis. Biopsy strategy depends on the question.

Small-bowel imaging is not routine for every chronic diarrhea case. CT or MR enterography may be used when Crohn disease, a mass, or other small-bowel pathology is suspected. Pancreatic imaging and fecal elastase are used when pancreatic insufficiency is plausible, particularly with greasy stools, nutrient deficiencies, weight loss, or pancreatic history.

Treatment: Match the Cause and Severity

Oral rehydration

Fluid and electrolyte replacement is the first treatment when diarrhea is causing losses. Packaged oral rehydration salts mixed with the stated volume of safe water provide a glucose-sodium balance designed for absorption. The World Health Organization identifies low-osmolarity ORS as a proven treatment, with intravenous fluids reserved for severe dehydration or shock. 11

For mild diarrhea in an otherwise healthy adult, preferred fluids and salty foods may be adequate. Very sweet drinks can worsen osmotic diarrhea when consumed in large amounts. Children, frail older adults, and people with kidney or heart disease need more individualized fluid decisions.

Food during recovery

Prolonged fasting or a restrictive BRAT-only diet is usually unnecessary. Resume tolerable, nutritionally complete food as appetite returns. Smaller portions, lower-fat foods, starches, soup, yogurt if tolerated, fruit, vegetables, and lean protein are reasonable. Temporary lactose intolerance can follow gastroenteritis, but routine long-term dairy elimination is not required.

Loperamide and bismuth

Loperamide can reduce stool frequency in selected adults with acute watery diarrhea. It should not be used alone for bloody diarrhea or diarrhea with fever, and it is not a substitute for evaluation when severe disease is possible. Bismuth subsalicylate can help some cases but has salicylate-related contraindications and can darken stool and tongue.

Antibiotics

Empiric antibiotics are not recommended for most uncomplicated acute watery diarrhea without recent international travel. They may shorten selected bacterial traveler’s diarrhea, but they can also cause adverse effects, promote resistance, increase CDI risk, and be harmful in suspected STEC.

For travelers, the CDC Yellow Book classifies illness by functional impact. Antibiotics are not recommended for mild traveler’s diarrhea; they can be used for moderate disease and are advised for severe disease, with azithromycin preferred for dysentery or febrile diarrhea. Region, resistance, allergies, age, pregnancy, and invasiveness matter. 12

Rifaximin is approved for traveler’s diarrhea caused by noninvasive E. coli. It should not be used when invasive pathogens such as Campylobacter, Salmonella, or Shigella are suspected. The CDC notes that travelers cannot reliably distinguish invasive from noninvasive disease, which limits rifaximin as empiric self-treatment. It is not routine prophylaxis. 12

C. difficile treatment

CDI treatment depends on severity, episode history, recurrence risk, ileus, and access. The 2021 IDSA/SHEA focused update suggests fidaxomicin over a standard vancomycin course for an initial episode when resources allow, while vancomycin remains an acceptable alternative. Recurrence options differ from first-episode treatment. 13

The 2026 AGA update favors fidaxomicin for nonfulminant CDI because of lower recurrence, with oral vancomycin acceptable in practice, and reserves different combined management for fulminant disease. 5 This is why a generic online dose list is not a safe substitute for severity classification.

Chronic diarrhea treatment

Treatment follows the diagnosis:

• celiac disease requires a strict gluten-free diet after appropriate diagnosis
• microscopic colitis often responds to budesonide, with relapse and maintenance decisions individualized
• bile acid diarrhea may respond to a bile acid sequestrant
• pancreatic insufficiency may require pancreatic enzyme replacement
• IBS-D may be treated with diet, gut-brain therapy, or approved medicines based on the symptom pattern
• IBD therapy depends on disease type, location, severity, and treatment goals

Using an IBD biologic, rifaximin, budesonide, or a bile acid binder before establishing the correct branch can delay diagnosis or create avoidable harm.

GLP-1 or Tirzepatide-Associated Diarrhea

Diarrhea that begins after starting or increasing an incretin medicine may be drug-related, but not every episode is. Bloody stool, high fever, severe pain, persistent vomiting, marked dehydration, recent antibiotics, or an outbreak exposure still requires a broader assessment.

A medication review should examine dose timing, escalation rate, other diarrhea-causing products such as metformin or magnesium, oral intake, and symptom severity. Management may include hydration, dietary adjustment, delaying escalation, dose modification, or another medication decision. Automatically stopping for a fixed two to four weeks is not a universal diagnostic rule.

Infection Control at Home

Soap-and-water handwashing is especially important after bathroom use and before food preparation. Clean contaminated bathroom and high-touch surfaces with a product appropriate for the suspected organism. Do not prepare food for others while actively ill and follow local public-health or workplace rules for return after vomiting or diarrhea.

Norovirus spreads easily and is resistant to some routine cleaning approaches. CDI also requires particular attention to environmental cleaning and hand hygiene. A diagnosis or outbreak setting may add organism-specific instructions.

What to Bring to a Visit

A concise record can prevent duplicate testing:

1. start date and trajectory
2. maximum and current stools per day
3. stool appearance, including blood, black color, grease, or mucus
4. fever, vomiting, pain, nighttime symptoms, and weight change
5. urine output and fluids tolerated
6. recent antibiotics, hospital care, travel, water, food, animals, and sick contacts
7. complete medicine and supplement list with start or dose-change dates
8. prior stool, blood, imaging, or endoscopy results

The goal is not to request every test. It is to make the right diagnostic branch visible.